ACLX News and Press, Arcellx Inc. From 11/15/23

2023-11-15 06:39:59 ET More on Arcellx Arcellx: Clinical Hold Lifted, Charting A Brighter Path Forward (Rating Upgrade) Arcellx jumps after data for Gilead-partnered multiple myeloma drug Seeking Alpha’s Quant Rating on Arcellx Historical earnings data...

ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP PR Newswire -- Arcellx to receive $200M equity investment at $61.68 per share and an $85 million upfront cash payment -- -- Kite exercises option to Arcellx's ARC-SparX program ACLX-001 in multiple myel...

-- The companies expand the scope of their existing collaboration for CART-ddBCMA to include lymphomas -- -- Kite exercises option to Arcellx’s ARC-SparX program ACLX-001 in multiple myeloma -- -- Arcellx to receive $200M equity investment at $61.68 per share and an $85 mil...

2023-11-14 01:59:56 ET More on Arcellx Arcellx: Clinical Hold Lifted, Charting A Brighter Path Forward (Rating Upgrade) Arcellx jumps after data for Gilead-partnered multiple myeloma drug Seeking Alpha’s Quant Rating on Arcellx Historical earnings data...

Arcellx Provides Third Quarter 2023 Financial Results and Business Highlights PR Newswire -- Recently released ASH abstract for the company's Phase 1 CART-ddBCMA trial demonstrated that median duration of response, progression free survival, and overall survival not reached...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Arcellx Inc. (ACLX) is expected to report $-0.56 for Q3 2023

2023-11-02 12:44:44 ET More on Arcellx, Gilead, etc. Gilead Sciences Stock Is Cheap, With Broad Pipeline Gilead Sciences: Does The Stocks Reward Outweigh The Risk Gilead Sciences: A Healthy Buy With Solid Dividend Eli Lilly, Gilead favorites at BofA ahead of ...

2023-11-02 10:01:01 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in F...

Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and Exposition PR Newswire -- Abstract released today is from a June 2, 2023 data cut -- -- Median duration of re...